Skip to main content
Caplight Logo









VascuBio Innovation

VascuBio Innovation

Private
TorontoHealthcare & Life Scienceshttps://vascubio.com/

Last Round

Accelerator

Mar 12, 2026

Total Funding Raised

$299,431

Momentum

Top 50%

of companies Caplight tracks

Company Overview

VascuBio Innovation is a life sciences company that develops advanced 3D bioprinting, bioreactor, and microfluidic platforms for tissue engineering and diagnostic applications.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Medical Devices, 3D Printing, Biotech Equipment

Business Model

B2B

Customer Profile

Hardware Sales, Services & Consulting, Government Contracts

AI Layer

Application

Keywords

organ-on-chip3d bioprintingmicrofluidic devicestissue engineeringdrug discoverybioreactor systemsbiomaterialsdisease modelinglab-on-a-chipin vitro modelsbiotech equipmentregenerative medicinephotopolymer resinanimal-free testingpoint-of-care diagnostics

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

VascuBio Innovation Comparables

Compare VascuBio Innovation with similar companies based on industry and business-model similarity.

VascuBio Innovation comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
VoxCell BioInnovation
90%
FluidForm Bio
85%
TissUse
84%

VascuBio Innovation Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
AcceleratorMar 12, 2026
GrantNov 20, 2025
GrantMar 31, 2025

Key People

Founding team and executive leadership

Vahid Karamzadeh

CTO & Co-Founder

Founding Team

VascuBio Innovation Investors

Notable investors and investment history

VascuBio Innovation investors
InvestorRounds
Consortium Québécois sur la découverte du médicamentGrant
Gouvernement du QuébecGrant
Ontario GenomicsAccelerator

Market signals

Structured signals derived from secondary market and firmographic data.

  • Mar 12, 2026

    $150K raised from Federal Economic Development Agency and Ontario Genomics.

  • Nov 20, 2025

    Received funding from Consortium Québécois, Gouvernement du Québec, and Pfizer Canada.

VascuBio Innovation Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

VascuBio Innovation Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about VascuBio Innovation's valuation, stock price, and market status.

Firmographic Details

HeadquartersToronto
Employee Range5
Year Founded2023
Last FundingMar 12, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?